Physician

Hui Liu, M.D.

According to 2025 Medicare claims, Hui Liu, M.D. (NPI: 1487898235) practices nephrology in the Bangor, ME market, with the plurality of this provider's patient population coming from Penobscot, ME. This provider's primary affiliated billing organization is NORTHEAST NEPHROLOGY PA (NPI: 1336145200; TIN: 01-0521643) and primary practice location at 04401-6614. Liu is affiliated with the Community Care Partnership of Maine, LLC (ACO ID: A2831) and Beacon Rural Health, LLC (ACO ID: A5614), participating under the MSSP model.

Liu's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 1,012 HCPCS/CPT codes, and received $103,248 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 657 prescription claims across 164 beneficiaries totaling $69,013 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 81 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $26,380 and ending at $103,248. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	88	316	$26,380
2016	509	1,627	$163,104
2017	513	1,466	$130,069
2018	540	1,561	$179,438
2019	575	1,871	$196,175
2020	550	2,016	$209,997
2021	507	1,629	$167,999
2022	450	1,454	$166,658
2023	353	970	$104,933
2024	363	1,012	$103,248

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	49	136	$21,497
2016	184	652	$116,523
2017	223	894	$155,184
2018	261	1,026	$142,341
2019	229	890	$104,924
2020	217	847	$113,895
2021	200	823	$129,361
2022	201	713	$114,634
2023	189	706	$109,134
2024	164	657	$69,013

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	56	$2,391
2018	N/R	31	$2,580
2019	N/R	70	$1,808
2020	N/R	N/R	N/R
2021	N/R	31	$467
2022	N/R	94	$2,412
2023	N/R	97	$1,244
2024	N/R	81	$1,213

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	80	123	$260
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	46	47	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	124	169	$79
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	108	307	$56
90935	Hemodialysis procedure with physician evaluation	67	218	$51

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	17	1,090	$20,485
Sevelamer Carbonate	Sevelamer Carbonate	38	2,505	$14,764
Calcium Acetate	Calcium Acetate	15	622	$1,728
Calcitriol	Calcitriol	59	4,140	$880
Furosemide	Furosemide	114	9,657	$696

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	19	$360
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	18	$320
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	26	$314
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	18	$220

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Hui Liu, M.D.?

Tedicare shows public-source Medicare data for Hui Liu, M.D. (NPI 1487898235), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hui Liu, M.D. have ACO affiliation data?

Hui Liu, M.D. is shown with ACO affiliation data for Community Care Partnership of Maine, LLC (MSSP, ACO ID A2831) and Beacon Rural Health, LLC (MSSP, ACO ID A5614).

What billing organization is linked to Hui Liu, M.D.?

Hui Liu, M.D. is linked to NORTHEAST NEPHROLOGY PA (billing NPI 1336145200) in the available physician profile data.

Does Hui Liu, M.D. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.